Loss of heterozygosity of the retinoblastoma gene in liver cirrhosis accompanying hepatocellular carcinoma

Journal of Cancer Research and Clinical Oncology

Volumn 123, Issue 9, 1997, Pages 489-495

  Ashida, Kumiyo ^a   Kishimoto, Yosuke ^a   Nakamoto, Kentaro ^a   Wada, Kouichirou ^a   Shiota, Goshi ^a   Hirooka, Yasuaki ^a   Kamisaki, Yoshinori ^a   Itoh, Tadao ^a   Kawasaki, Hironaka ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

Hepatocellular carcinoma; Liver cirrhosis; Loss of heterozygosity; Retinoblastoma gene

Indexed keywords

ARTICLE; CANCER GENETICS; CANCER SURGERY; CHROMOSOME MICRODISSECTION; CLINICAL ARTICLE; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER SURGERY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0030777199     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01192203     Document Type: Article

References (57)

1. Borg A, Zhang QX, Alm P, Olsson H, Sellberg G (1992) The retinoblastoma gene in breast cancer: allele loss is not correlated with loss of gene protein expression. Cancer Res 52:2991-2994
2. Bressac B, Galvin KM, Liang TJ, Isselbacher KJ, Wands JR, Ozturk M (1990) Abnormal structure and expression of p53 gene in human hepatocellular carcinoma. Proc Natl Acad Sci USA 87:1973-1977
3. Bressac B, Kew M, Wands J, Ozturk M (1991) Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 350:429-431
4. Buetow KH, Murray JC, Israel JL, London WT, Smith M, Kew M, Blanquet V, Brechot C, Redeker A, Govindarajah S (1989) Loss of heterozygosity suggests tumor suppressor gene responsible for primary hepatocellular carcinoma. Proc Natl Acad Sci USA 86:8852-8856
5. Cance WG, Brennan MF, Dudas ME, Huang CM, Cordon-Cardo C (1990) Altered expression of the retinoblastoma gene product in human sarcomas. N Engl J Med 323:1457-1462
6. Cordon-Cardo C, Wartinger D, Petrylak D, Dalbagni G, Fair WR, Fuks Z, Reuter VE (1992) Altered expression of the retinoblastoma gene product: prognostic indicator in bladder cancer. J Natl Cancer Inst 84:1251-1256
7. Ding S-F, Habib NA, Dooley J, Wood C, Bowles L, Delhanty JDA (1991 ) Loss of constitutional heterozygosity on chromosome 5q in hepatocellular carcinoma without cirrhosis. Br J Cancer 64:1083-1087
8. Edmondson HA, Steiner PE (1954) Primary carcinoma of the liver. A study of 100 cases among 48,900 necropsies. Cancer 7:462-503
9. Emi M, Fujiwara Y, Nakajima T, Tsuchiya E, Tsuda H, Hirohashi S, Maeda Y, Tsuruta K, Miyaki M, Nakamura Y (1992) Frequent loss of heterozygosity for loci on chromosome 8p in hepatocellular carcinoma, colorectal cancer and lung cancer. Cancer Res 52:5368-5372
10. Figge J, Bakst G, Weisheit D, Solis O, Ross JS (1991) Image analysis quantitation of immunoreactive retinoblastoma protein in human thyroid neoplasms with a streptavidin-biotin-peroxidase staining technique. Am J Pathol 139:1213-1219
11. Fujimori M, Tokino T, Hino O, Kitagawa T, Imamura T, Okamoto E, Mitsunobu M, Ishikawa T, Nakagama H, Harada H, Yagura M, Matsubara K, Nakamura Y (1991) Allelotype study of primary hepatocellular carcinoma. Cancer Res 51:89-93
12. Fujimoto J, Okamoto E, Yamanaka N, Toyosaka A, Mitsunobu M (1991) Flow cytometric DNA analysis of hepatocellular carcinoma. Cancer 67:939-944
13. Haber DA, Housman DE (1992) Role of the WT1 gene in Wilms' tumour. Cancer Surv 12:105-117
14. Hensel CH, Hsieh C-L, Gazdar AF, Johnson BE, Sakaguchi AY, Naylor SL, Lee W-H, Lee EY-HP (1990) Altered structure and expression of the human retinoblastoma susceptibility gene in small cell lung cancer. Cancer Res 50:3067-3072
15. Hinds PW, Mittnacht S, Dulic V, Arnold A, Reed SI, Winberg RA (1992) Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 70:993-1006
16. Horii A, Nakatsuru S, Miyoshi Y, Ichii S, Nagase H, Ando H, Yanagisawa A, Tsuchiya E, Kato Y, Nakamura Y (1992) Frequent somatic mutations of the APC gene in human pancreatic cancer. Cancer Res 52:6696-6698
17. Hsia CC, Di Bisceglie AM, Kleiner DE, Farshid M, Tabor E (1994) RB tumor suppressor gene expression in hepatocellular carcinomas from patients infected with the hepatitis B virus. J Med Virol 44:67-73
18. Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC (1991) Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 350:427-428
19. Hung J, Kishimoto Y, Sugio K, Virmani A, McIntire DD, Minna JD, Gazdar AF (1995) Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma. JAMA 273:558-563
20. Ishizu H (1989) Flow cytometric analysis of the nuclear DNA content of hepatocellular carcinoma. Jpn J Surg 19:662-673
21. Iwao Y, Kim YI, Kaketani K, Nakashima K, Okada K, Kobayashi M (1993) Stemline heterogeneity of nuclear DNA in hepatocellular carcinoma. Hepatogastroenterology 40:491-495
22. Kato J, Matsushime H, Hiebert SW, Ewen ME, Sherr CJ (1993) Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRB phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev 7:331-342
23. Kishimoto Y, Sugio K, Hung JY, Virmani AK, McIntire DD, Minna JD, Gazdar AF (1995) Allele-specific loss in chromosome 9p loci in preneoplastic lesions accompanying non-small-cell lung cancers. J Natl Cancer Inst 87:1224-1229
24. Lerer I, Meiner V, Pashut-Lavon I, Abeliovich D (1994) Molecular diagnosis of Prader-Willi syndrome: parent-of-origin dependent methylation sites and non-isotopic detection of (CA), dinucleotide repeat polymorphisms. Am J Med Genet 52:79-84
25. Liver Cancer Study Group of Japan (1990) Primary liver cancer in Japan. Ann Surg 211:277-287
26. Logothetis CJ, Xu HJ, Ro JY, Hu SX, Sahin A, Ordonez N, Benedict WF (1992) Altered expression of retinoblastoma protein and known prognostic variables in locally advanced bladder cancer. J Natl Cancer Inst 84:1256-1261
27. Marshall CJ (1991) Tumor suppressor genes. Cell 64:313-326
28. McEntee GP, Batts KA, Katzmann JA, Ilstrup DM, Nagorney DM (1992) Relationship of nuclear DNA content to clinical and pathologic findings in patients with primary hepatic malignancy. Surgery 111:376-379
29. Miki Y, Nishisho I, Miyoshi Y, Utsunomiya J, Nakamura Y (1992) Interstitial loss of the same region of 5q in multiple adenomas and a carcinoma derived from an adenomatous polyposis coli (APC) patient. Genes Chromosomes Cancer 4:81-83
30. Murakami Y, Hayashi K, Hirohashi S, Sekiya T (1991) Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas. Cancer Res 51:5520-5525
31. Nagasue N, Kohno H, Hayashi T, Yamanoi A, Uchida M, Takemoto Y, Makino Y, Ono T, Hayashi J, Nakamura T (1993) Lack of intratumoral heterogeneity in DNA ploidy pattern of hepatocellular carcinoma. Gastroenterology 105:1449-1454
32. Nakamura T, Iwamura Y, Kaneko M, Nakagawa K, Kawai K, Mitamura K, Futagawa T, Hayashi H (1991) Deletions and rearrangements of the retinoblastoma gene in hepatocellular carcinoma, insulinoma and some neurogenic tumors as found in a study of 121 tumors. Jpn J Clin Oncol 21:325-329
33. Nishida N, Fukuda Y, Kokuryu H, Sadamoto T, Isowa G, Honda K, Yamaoka Y, Ikenaga M, Imura H, Ishizaki K (1992) Accumulation of allelic loss on arms of chromosomes 13q, 16q and 17p in the advanced stages of human hepatocellular carcinoma. Int J Cancer 51:862-868
34. Nishida N, Eukuda Y, Kokuryu H, Toguchida J, Yandell DW, Ikenaga M, Imura H, Ishizaki K (1993) Role and mutational heterogeneity of the p53 gene in hepatocellular carcinoma. Cancer Res 53:368-372
35. Oda T, Tsuda H, Scarpa A, Sakamoto M, Hirohashi S (1992a) Mutation pattern of the p53 gene as a diagnostic marker for multiple hepatocellular carcinoma. Cancer Res 52:3674-3678
36. Oda T, Tsuda H, Scarpa A, Sakamoto M, Hirohashi S (1992b) p53 gene mutation spectrum in hepatocellular carcinoma. Cancer Res 52:6358-6364
37. Okada S, Ishii H, Nose H, Okusaka T, Kyogoku A, Yoshimori M, Sakamoto M, Hirohashi S (1995) Intratumoral DNA heterogeneity of small hepatocellular carcinoma. Cancer 75:444-450
38. Okuda K (1992) Hepatocellular carcinoma: recent progress. Hepatology 15:948-963
39. Pääbo S (1989) Ancient DNA: extraction, characterization, molecular cloning, and enzymatic amplification. Proc Natl Acad Sci USA 86:1939-1943
40. Reich NC, Levine AJ (1984) Growth regulation of a cellular tumour antigen, p53, in nontransformed cells. Nature 308:199-201
41. Roger CE, Chisari FV (1992) Cellular and molecular mechanism of hepatocarcinogenesis. Semin Liver Dis 12:265-278
42. Sakamoto M, Hirohashi S, Shimosato Y (1991) Early stages of multistep hepatocarcinogenesis: adenomatous hyperplasia and early hepatocellular carcinoma. Hum Pathol 22:172-178
43. Simon D, Knowles BB, Weith A (1991) Abnormalities of chromosome 1 and loss of heterozygosity on 1p in primary hepatomas. Oncogene 6:765-770
44. Stanbridge EJ (1992) Functional evidence for human tumour suppressor genes: chromosome and molecular genetic studies. Cancer Surv 12:5-24
45. Sugio K, Kishimoto Y, Virmani AK, Hung JY, Gazdar AF (1994) K-ras mutations are a relatively late event in the pathogenesis of lung carcinomas. Cancer Res 54:5811-5815
46. Sundaresan V, Ganly P, Hasleton P, Rudd R, Sinha G, Blechen NM, Rabbitts P (1992) p53 and chromosome 3 abnormalities, characteristic of malignant lung tumours, are detectable in preinvasive lesions of the bronchus. Oncogene 7:1989-1997
47. Takahashi K, Kudo J, Ishibashi H, Hirata Y, Niho Y (1993) Frequent loss of heterozygosity on chromosome 22 in hepatocellular carcinoma. Hepatology 17:794-799
48. Tanaka S, Toh Y, Adachi E, Matsumata T, Mori R, Sugimachi K (1993) Tumor progression in hepatocellular carcinoma may be mediated by p53 mutation. Cancer Res 53:2884-2887
49. T'Ang A, Varley JM, Chakraborty S, Murphree AL, Fung Y-KT (1988) Structural rearrangement of the retinoblastoma gene in human breast carcinoma. Science 242:263-266
50. Toguchida J, McGee TL, Paterson JC, Eagle JR, Tucker S, Yandell DW, Dryja TP (1993) Complete genomic sequence of the human retinoblastoma susceptibility gene. Genomics 17:535-543
51. Tsuda H, Zhang W, Shimosato Y, Yokota J, Terada M, Sugimura T, Miyamura T, Hirohashi S (1990) Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma. Proc Natl Acad Sci USA 87:6791-6794
52. Walker GJ, Hayward NK, Falvey S, Cooksley WGE (1991) Loss of somatic heterozysosity in hepatocellular carcinoma. Cancer Res 51:4367-4370
53. Wang HP, Rogler CE (1988) Deletions in human chromosome arms lip and 13q in primary hepatocellular carcinomas. Cytogenet Cell Genet 48:72-78
54. Wistuba II, Sugio K, Hung J, Kishimoto Y, Virmani AK, Roa I, Albores-Saavedra J, Gazdar AF (1995) Allele-specific mutations involved in the pathogenesis of endemic gallbladder carcinoma in Chile. Cancer Res 55:2511-2515
55. Xu H-J, Hu S-X, Cagle PT, Moore GE, Benedict WF (1991) Absence of retinoblastoma protein expression in primary non-small cell lung carcinomas. Cancer Res 51:2735-2739
56. Zhang W, Hirohashi S, Tsuda H, Shimosato Y, Yokota J, Terada M, Sugimura T (1990) Frequent loss of heterozygosity on chromosomes 16 and 4 in human hepatocellular carcinoma. Jpn J Cancer Res 81:108-111
57. Zhang X, Xu HJ, Murakami Y, Sachse R, Yashima K, Hirohashi S, Hu SX, Benedict WF, Sekiya T (1994) Deletions of chromosome 13q, mutations in retinoblastoma 1, and retinoblastoma protein state in human hepatocellular carcinoma. Cancer Res 54:4177-4182